Adipocyte volumes and levels of adipokines in diabetes and obesity

Basit Öğe Kaydı
dc.contributor.authorGokalp, Deniz
dc.contributor.authorBahceci, Mithat
dc.contributor.authorOzmen, Sehmus
dc.contributor.authorArikan, Senay
dc.contributor.authorTuzcu, Alpaslan
dc.contributor.authorDanis, Ramazan
dc.date.accessioned2024-04-24T16:11:17Z
dc.date.available2024-04-24T16:11:17Z
dc.date.issued2008
dc.departmentDicle Üniversitesien_US
dc.description.abstractAim: Obesity is a major risk factor for insulin resistance, type 2 diabetes, heart disease, and many other chronic diseases. The factors regulating cytokine production seem to have a role on the determination of adipocyte volume. We aimed to investigate the association of plasma adiponectin and resistin concentrations with adipocyte volumes in obese, diabetic, obese-diabetic and control groups. Methods: Plasma adiponectin, resistin and lipid levels and adipocyte volumes were investigated in obese, non-diabetic, non-obese diabetic, obese diabetic and control groups consisting 100 subjects who planned to undergo elective surgery. Differences in clinical or laboratory parameters among groups were compared by using one-way ANOVA test. Chi-square test was used for comparing the frequencies. Results: The lipid values in all three groups were higher than the control group. A negative correlation was found between adiponectine levels and adipocyte volumes. When adipocyte volumes were compared with other groups, adipocyte volumes were significantly higher in the obese diabetic group (p = 0.000). The adipocyte volumes in the obese group were determined to be higher than the control group. Conclusions: Although a positive correlation was found between adipocyte volumes and adiponectin in literature, adiponectin concentrations in our study were lower. These conditions can be explained by the effect of insulin resistance on the adiponectin levels in obese diabetic groups. Moreover, adiponectin levels are mostly associated with subcutaneous adipose tissue which may have been less. Resistin levels may play an important role in the development of obesity, insulin resistance and diabetes. (C) 2008 Diabetes India. Published by Elsevier Ltd. All rights reserved.en_US
dc.identifier.doi10.1016/j.dsx.2008.07.001
dc.identifier.endpage258en_US
dc.identifier.issn1871-4021
dc.identifier.issn1878-0334
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-55549117782
dc.identifier.scopusqualityQ1
dc.identifier.startpage253en_US
dc.identifier.urihttps://doi.org/10.1016/j.dsx.2008.07.001
dc.identifier.urihttps://hdl.handle.net/11468/15340
dc.identifier.volume2en_US
dc.identifier.wosWOS:000215373800004
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoenen_US
dc.publisherElsevier Sci Ltden_US
dc.relation.ispartofDiabetes & Metabolic Syndrome-Clinical Research & Reviews
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAdiponectinen_US
dc.subjectResistinen_US
dc.subjectAdipocyte Volumeen_US
dc.subjectObesityen_US
dc.subjectDiabetesen_US
dc.titleAdipocyte volumes and levels of adipokines in diabetes and obesityen_US
dc.titleAdipocyte volumes and levels of adipokines in diabetes and obesity
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu